• SPX
  • $5,712.69
  • -0.28 %
  • -$16.11
  • DJI
  • $41,794.60
  • -0.61 %
  • -$257.59
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,184.21
  • -0 %
  • -$0.03
  • IXIC
  • $18,179.98
  • -0.33 %
  • -$59.93
Apellis Pharmaceuticals, Inc. (APLS) Insider Traders

Apellis Pharmaceuticals, Inc. (APLS) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$28.57

$0.59

(2.11%)

Day's range
$27.47
Day's range
$30.13
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    0
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    11
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $0
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $39.19 M

Apellis Pharmaceuticals, Inc. Insider Transactions

Apellis Pharmaceuticals, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Sell 29,476 @ $36.09 $1.06 M 107,524 09/16/2024 09/17/2024
Sell 7,524 @ $36.79 $276,808 100,000 09/16/2024 09/17/2024
Sell 192 @ $36.21 $6,952 38,141 09/16/2024 09/17/2024
Sell 550 @ $39.49 $21,720 38,333 09/03/2024 09/04/2024
Sell 35,305 @ $39.22 $1.38 M 138,693 06/21/2024 06/21/2024
Sell 1,695 @ $39.63 $67,173 136,998 06/21/2024 06/21/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 100 @ $44.03 $4,403 1,115,983 05/08/2024 05/09/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 56,335 @ $42.15 $2.37 M 1,138,555 05/08/2024 05/09/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 22,472 @ $42.85 $962,903 1,116,083 05/08/2024 05/09/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 64,379 @ $54.12 $3.48 M 1,120,711 04/08/2024 04/09/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 4,728 @ $54.92 $259,639 1,115,983 04/08/2024 04/09/2024
Sell 4,000 @ $58.66 $234,640 93,338 04/01/2024 04/02/2024
Sell 18,681 @ $57.18 $1.07 M 173,998 03/19/2024 03/20/2024
DeLong Mark Jeffrey

Chief Business & Strat Officer

Sell 9,913 @ $56.90 $564,050 54,693 03/18/2024 03/19/2024
Sell 184 @ $56.46 $10,389 38,883 03/15/2024 03/18/2024
Nicholson Nur

Chief Technical Officer

Sell 7,768 @ $57.31 $445,161 59,739 03/13/2024 03/14/2024
Nicholson Nur

Chief Technical Officer

Sell 3,452 @ $58.13 $200,677 56,287 03/13/2024 03/14/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 42,750 @ $61.88 $2.65 M 1,142,340 03/08/2024 03/11/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 26,257 @ $62.69 $1.65 M 1,116,083 03/08/2024 03/11/2024
Deschatelets Pascal

Chief Scientific Officer

Sell 100 @ $63.35 $6,335 1,115,983 03/08/2024 03/11/2024

Apellis Pharmaceuticals, Inc. Frequently Asked Questions

  • Who is on Apellis Pharmaceuticals, Inc.'s Insider Roster?

    The list of insiders at Apellis Pharmaceuticals, Inc. includes Sullivan Timothy Eugene, Townsend Adam J., Watson David O., Nicholson Nur, DeLong Mark Jeffrey, Lewis Karen, Chopas James George, Deschatelets Pascal, Eisele Jeffrey, Francois Cedric, Dunlop A. Sinclair.

  • How much insider selling is happening at Apellis Pharmaceuticals, Inc.?

    Insiders have sold a total of 684,413 Apellis Pharmaceuticals, Inc. shares in the last 12 months for a total of 39.19 M sold.

  • Which Apellis Pharmaceuticals, Inc. insiders have been selling company stock?

    The following insiders have sold Apellis Pharmaceuticals, Inc. shares in the last 12 months: Sullivan Timothy Eugene ($1.15 M), Townsend Adam J. ($507,054), Watson David O. ($666,247), Nicholson Nur ($991,991), DeLong Mark Jeffrey ($826,965), Lewis Karen ($791,212), Chopas James George ($165,744), Deschatelets Pascal ($11.88 M), Eisele Jeffrey ($997,353), Francois Cedric ($17.35 M), Dunlop A. Sinclair ($3.86 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.